Business Wire

FOURKITES

9.3.2022 10:02:09 CET | Business Wire | Press release

Share
FourKites Unveils Robust Net Zero Initiative at World’s Largest Global Supply Chain Sustainability Event in Amsterdam

FourKites , provider of the world’s leading real-time supply chain visibility platform , today announced its new Net Zero initiative to help the world’s leading companies achieve their organisational goals to reduce supply chain emissions. As part of this announcement, FourKites unveiled Sustainability Hub, a suite of analytics tools to provide better visibility into resource consumption and waste generation; a new Sustainability Advisory Board; and ongoing original research around sustainability.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220309005093/en/

Sustainability Hub is the latest phase of FourKites’ ongoing focus to help companies scale sustainability efforts through technology and collaboration. The platform will include new tools and capabilities that enable customers to:

  • Input their sustainability goals and more accurately track saved emissions
  • Benchmark progress against industry averages based on organisational goals and anonymised industry data
  • Drill down into additional load-level details to better pinpoint opportunities for optimisation
  • Track progress via a single summary dashboard
  • Use analytics and scenario modeling to surface new insights for emissions reductions

Sustainability Hub builds on the company’s industry-first Sustainability Dashboards , a free solution that allows companies to identify specific areas within their supply chains that are contributing high levels of greenhouse gas emissions so that they can develop more effective sustainability strategies.

The announcement coincides with FourKites’ 2022 Global Supply Chain Sustainability Summit that is bringing together more than 4,000 supply chain executives and sustainability thought leaders from organisations including Sony, AB InBev, DHL, Future Planet, Volvo Group and others, to discuss how to drive positive environmental impact through supply chain transformation.

According to Gartner, “We cannot scale the sustainability agenda without technology. CSCOs expect the focus on digitalisation to increase. Seventy-two percent stated that enterprises will continue to digitise and integrate new technologies, meaning supply chains will have to continuously adapt.”* To that end, FourKites has continued to drive innovation in the industry and facilitate discussion among key stakeholders across the industry in order to help companies meet their long-term sustainability goals.

“We started using FourKites years ago because we knew it was important to have visibility in transit,” said Paul Avampato, Head of International Logistics for Laundry and Home Care at Henkel. “Now we’re using that data to drive efficiencies in our supply chain and help achieve our sustainability goals.”

Sustainability Hub is the latest component of FourKites’ multi-faceted strategy to help customers achieve their sustainability goals. Other programs and solutions include:

“Sustainability is a core tenet of our philosophy at FourKites, and we are hyper-focused on enabling our Fortune 1000 customers to embed sustainability throughout every level of their supply chain,” said FourKites Founder and CEO Mathew Elenjickal. “I am incredibly proud of our team for driving the sustainability agenda for the industry and helping our customers make a meaningful impact on the environment.”

*Gartner, “CSCO Response to Environmental Sustainability Trends for Supply Chain in 2022,” Sarah Watt, Laura Rainier, Heather Wheatley, Simon Bailey, Andrew Stevens, Kristin Moyer. Published 24 January 2022.

About FourKites

FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching over 185 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,000 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye